Serum Vascular Endothelial Growth Factor/Soluble Vascular Endothelial Growth Factor Receptor 1 Ratio Is an Independent Prognostic Marker in Pancreatic Cancer | Zendy

YuTing Chang | Zendy; MingChu Chang | Zendy; ShuChen Wei | Zendy; YuWen Tien | Zendy; Chiun Hsu | Zendy; PoChin Liang | Zendy; PoNien Tsao | Zendy; IShiow Jan | Zendy; JauMin Wong | Zendy

Open Access

Serum Vascular Endothelial Growth Factor/Soluble Vascular Endothelial Growth Factor Receptor 1 Ratio Is an Independent Prognostic Marker in Pancreatic Cancer

Author(s) -

YuTing Chang,

MingChu Chang,

ShuChen Wei,

YuWen Tien,

Chiun Hsu,

PoChin Liang,

PoNien Tsao,

IShiow Jan,

JauMin Wong

Publication year - 2008

Publication title -

pancreas

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.061

H-Index - 104

eISSN - 1536-4828

pISSN - 0885-3177

DOI - 10.1097/mpa.0b013e318164548a

Subject(s) - pancreatic cancer , vascular endothelial growth factor , medicine , angiogenesis , vascular endothelial growth factor c , cancer , oncology , adenocarcinoma , endocrinology , vascular endothelial growth factor a , gastroenterology , vegf receptors

Tumor angiogenesis is the consequence of an imbalance between positive and negative angiogenic regulatory factors. We sought to determine the role of pretreated serum angiogenic factors, including vascular endothelial growth factor (VEGF), placental growth factor (PlGF), and soluble vascular endothelial growth factor receptor 1 (sVEGFR-1), in predicting clinical outcome in patients with pancreatic cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research